It has the capacity to enhance the expression of vascular endothelial growth factor (VEGF) and promote the activation of the VEGF—VEGF receptor-2 (VEGFR2) pathway to facilitate the generation of blood vessels to meet the needs of continuously proliferating tumor cells (30). The gene discussed is KDR; the disease is neoplasm.